Dr. Gillett & James O'Hara discuss the FDA ruling on MDMA.
00:00 Intro
01:10 FDA's decision on MDMA therapy is pending, with possibilities ranging from approval.
06:00 MDMA affects various hormones post-consumption, including serotonin and cortisol, potentially impacting mood and physiology.
09:30 MDMA trials for PTSD
14:55 Concerns over MDMA trials
21:32 FDA critiques MDMA therapy training protocols for therapists to prevent abuse.
24:33 MDMA is considered safer compared to benzodiazepines in certain respects.
27:33 Balancing drug accessibility and safety through regulatory measures is crucial to advancing scientific research and ensuring public health.
29:30 Outro
Studies/References:
► https://sci-hub.se/https://pubmed.ncbi.nlm.nih.gov/31734398/
► https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205851/
► https://www.nature.com/articles/s41591-023-02565-4
► https://abcnews.go.com/Health/fda-advisers-recommending-mdma-treatment-ptsd/story?id=110808948
For High-Quality Labs:
► https://gilletthealth.com/order-lab-panels/
For information on the Gillett Health clinic, lab panels, and health coaching:
► https://GillettHealth.com
Follow Gillett Health for more content from James and Kyle
► https://instagram.com/gilletthealth
► https://www.tiktok.com/@gilletthealth
► https://twitter.com/gilletthealth
► https://www.facebook.com/gilletthealth
Follow Kyle Gillett, MD
► https://instagram.com/kylegillettmd
Follow James O’Hara, NP
► https://Instagram.com/jamesoharanp
For 10% off Gorilla Mind products including SIGMA: Use code “GH10”
► https://gorillamind.com/
For discounts on high-quality supplements
►https://www.thorne.com/u/GillettHealth
#ptsd #fda #podcast
Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
